Take a look at our page for World Antibiotic Awareness Week, including some of our top content from the year, exclusive opinion pieces and a compilation of our #TalkAMR videos!
Browsing: Clinical > Antimicrobial Resistance
Antimicrobial resistance and sepsis are inherently interconnected issues, but are campaigns for antibiotic stewardship competing against sepsis awareness campaigns with regards to their messages on antibiotic use?
By carefully considering the characteristics of certain old and new antibiotics, it may be possible to overcome many bacterial resistance mechanisms, including when more than one is present.
A Phase II, muti-center, randomized, open-label trial has reported that a novel oral antibiotic, zoliflodacin, is effective in the treatment of uncomplicated urogenital gonorrhea.
A new study from the ECDC has estimated that 33,000 individuals die each year as a consequence of infections with antibiotic-resistant bacteria.
In this article, the authors discuss their research using non-ribosome targeting tobramycin-based adjuvants to overcome the intrinsic resistance observed in bacteria, Pseudomonas aeruginosa.
A new survey has reported that nearly half of parents have kept leftover antibiotics, and of these 73% have shared the drugs with other family and non-family.
In recent years, researchers have discovered the potential of CRISPR as an antimicrobial. In this blog post we explain the recent advances made in this field and the different approaches by which CRISPR can be used as a new weapon in the battle against antimicrobial resistance.
Gauri Godbole, from Public Health England, gives us an overview of recent advances and updates in the field of gastrointestinal infections – from the impact of the microbiome to the growing threat of antimicrobial resistance.